What Do Canopy Earnings Say About Cannabis ETFs?
Zacks Investment Research | Feb 19, 2020 01:00AM ET
It’s been a volatile journey for marijuana stocks in the past year. Earnings weakness, regulatory issues, “longer-than-anticipated product rollouts and overly enthusiastic forward estimates” hit the space hard. Most stocks lost more than half of their value.
Regulatory Backdrop & Earnings Hold the Key
Entering 2020, regulatory backdrop became extremely important. The latest report shows that Cannabis ETFs Are Soaring in 2020: Will the Trend Continue? ).
On a positive note, a U.S. congressional committee passed a legislation in late November to end the federal embargo on weed. But an approval by the full House and Senate should take time and will likely see many revisions in the process. Cannabis 2.0 — the next wave in the rollout of legal marijuana products in Canada — which kicked off in December, will act as the biggest catalyst for the industry. These are high-margin products including vapes, edibles (like chocolates, cookies and gummies) and infused beverages like juices and beer.
Against this backdrop, the companies started reporting quarterly results, wherein the industry biggie Canopy Growth Corporation (NYSE:CGC) sprang a sweet surprise to investors on Feb 14. The stock was up 13.4% on the day in response to its earnings results. The very financial release, in fact, acted as a cornerstone for the entire industry.
Tilray (NASDAQ:TLRY) was up 7.8% on the same day, HEXO Corp. (TSX:HEXO) gained 19.7%, Aurora Cannabis (TSX:ACB) added about 7.5%, Cronos Group Inc. (NASDAQ:CRON) returned 6.8% and Aphria Inc. (APHA) inched up 3.6%.
Inside Canopy’s Earnings
Canopy Growth offering dry cannabis and oil products, primarily under the Tweed and Bedrocan brands belongs to a favorable Zacks industry (placed at the top 33% of 250+ industries). Canopy's net revenue of $94.0 million and net loss of per share of 27 cents fared far better than the respective consensus estimate of $79 million revenues and a loss of 36 cents per share. Revenues jumped 49% year over year while losses were narrower than 67 cents witnessed in the year-ago-quarter.The gross margin rose from 13% to 34%, beating the consensus estimate of 25% .
ETFs in Focus
Such upbeat results from the biggest industry player gave hints that the prolonged downturn in the cannabis space could be a thing of the past now.
Given this scenario, investors can keep a close tab on marijuana ETFs like AdvisorShares Pure Cannabis ETF THCX (down 4.3%) and Global X Cannabis ETF (BO:POTX) (down 6.8%). These ETFs could be up for a rebound if there are more clear signs of recovery in the concerned domain.
Get The News You Want
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.